News: Gene therapy drugs step toward approval in Japan |
Novartis has applied with Japanese authorities to have a gene therapy drug approved, a move that could give Japan at least two such drugs in the coming year, Nikkei has learned. The Switzerland-based pharmaceutical hopes to receive the all-clear in Japan for a neurological disorder treatment sometime next year. It has also applied for approval for the same drug in the U.S. and Europe. In the U.S., the drug is said to be prohibitively expensive -- as much as $4 million to $5 million per patient. The drug treats spinal muscular atrophy, and Novartis expects to be able to market the treatment as early as next year. Read more... |
News: Infectivity of adeno-associated virus serotypes in mouse testis |
In a recent study, researchers from the Institute for Stem Cell Biology and Regenerative Medicine (InStem), Bengaluru, National Centre for Biological Sciences (NCBS), Bengaluru, Christian Medical College, Vellore and the Indian Institute of Technology, Kanpur, have described how a type of virus, called adeno-associated virus, behaves when injected into the mouse testis. The findings of the study, supported by the Department of Biotechnology (DBT) and InStem were published in the journal BMC Biotechnology. Read more... |
Conference: Gene Therapy - Ready for the Market? |
The last years were very promising for gene therapeutic approaches. However, development, manufacturing, quality control and clinical application of gene therapeutic products are very challenging – and still far from routine. The conference Gene Therapy – Ready for the Market? addresses the major issues on the way to save and successful products. You are invited to join from 30 - 31 January 2019 in Frankfurt, Germany, our renowned keynote speakers and to contribute to the program with your lecture or poster.
• Manufacturing and quality control of gene therapeutics • Genome editing for gene therapy development • Development and manufacturing of gene transfer vectors • Manufacturing of cell-based gene therapeutic products • Viral vectors for vaccination • Clinical applications of gene therapeutic products • Regulatory pathways to enable gene therapy
We look forward to your paper and to meeting you in Frankfurt! The conference is an initiative of the DECHEMA working groups Cell Culture Technology and Medical Biotechnology.
Register now... |
Medical Tourism Directory |
The goal with the Medical Tourism Directory is to help people around the world to find a fast and affordable medical treatment.
Medical tourism is not a new concept. In fact, it dates as far back as Ancient Greece. Luckily, it evolved into a tourism branch now providing patients with opportunity to travel and at the same time receive the most affordable medical care in foreign countries.
This health tourism and dental tourism are nowadays particularly popular in countries as various as Cuba, Mexico, India, Malaysia, Turkey, Greece, Germany, Canada, Australia, Israel, Dubai as well as the best hospitals in the US. In fact, Asian countries’ popularity is on the rise lately due to most recent technological and medical progress, hence engaging in medical tourism in India is the option worth considering.
That is why the Medical Tourism Directory suggest browsing through their search options, where the choice of specialties, treatments and conditions, complemented by country choice, can give you the medical vacations suggestions.
Read more... |
Conferences |
- |
23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK |
- |
26 - 27 November 2018, Opthalmic Drugs conference - Gene Therapy for the eye, London, UK |
- |
30 - 31 January 2019, CAR-T Congress EU, London, UK |
- |
30 - 31 January 2019, Gene Therapy – Ready for the Market?, Frankfurt am Main, Germany |
- |
6 - 7 February 2019, Annual Cell and Gene Therapy Innovation Summit, Berlin, Germany |
- |
4 - 6 March 2019, International Society for BioProcess Technology 9th Spring Meeting - Viral vectors and vaccines, Norfolk, Virginia |
- |
7 - 8 March 2019, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands |
- |
19 - 21 March 2019, 2nd Annual Bioprocessing Summit Europe - Cell and Gene Therapy, Lisbon, Portugal |
- |
21 - 22 March 2019, 9th International Conference and Exhibition on Advanced Cell and Gene Therapy, Rome, Italy |
- |
26 - 28 March 2019, 3rd Annual Gene Therapy for Rare Disorders, Boston, MA |
- |
2 – 4 April 2019, CAR-T Congress USA, Boston, MA |
- |
3 – 5 April 2019, 4th Spring school of the European Society of Gene and Cell Therapy (ESGCT), Naples, Italy |
- |
8 – 10 April 2019, 6th World Congress on Human Genetics and Genetic Diseases, Abu Dhabi, UAE |
- |
29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC |
- |
14 - 15 May 2019, Cell Series US Congress: Cell Culture & Bioprocessing and Cell & Gene Therapy, Boston, MA |
- |
15 - 17 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK |
- |
25 - 26 May 2019, Gordon Research Conference: Virusses & Cells, Lucca, Italy |
- |
19 - 21 June 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), Sheffield, UK |
- |
20 - 23 July 2019, The 25th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan |
- |
21 – 25 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain |
|
Read more... |
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
|
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}. |
|